Anemia: Perioperative Risk and Treatment Opportunity

Anesthesiology

Volumn 135, Issue 3, 2021, Pages 520-530

  Hare, Gregory M T ^a,b   Mazer, C David ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HYPOXIA INDUCIBLE FACTOR; IRON;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; ANEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HEART MUSCLE INJURY; HUMAN; IRON THERAPY; ORGAN INJURY; PERIOPERATIVE PERIOD; PREVALENCE; REVIEW; RISK FACTOR; BLOOD TRANSFUSION; COMPLICATION; POSTOPERATIVE COMPLICATION; PROCEDURES;

ANEMIA; BLOOD TRANSFUSION; HUMANS; IRON; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 85112394875     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000003870     Document Type: Review

References (62)

1. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW,: Iron deficiency. Lancet. 2021; 397: 233-48
2. Warner MA, Hanson AC, Frank RD, Schulte PJ, Go RS, Storlie CB, Kor DJ,: Prevalence of and recovery from anemia following hospitalization for critical illness among adults. JAMA Netw Open. 2020; 3: e2017843
3. Fowler AJ, Ahmad T, Abbott TEF, Torrance HD, Wouters PF, De Hert S, Lobo SM, Rasmussen LS, Della Rocca G, Beattie WS, Wijeysundera DN, Pearse RM, International Surgical Outcomes Study Group: Association of preoperative anaemia with postoperative morbidity and mortality: An observational cohort study in low-, middle-, and high-income countries. Br J Anaesth. 2018; 121: 1227-35
4. Karkouti K, Wijeysundera DN, Beattie WS, Reducing Bleeding in Cardiac Surgery (RBC) Investigators: Risk associated with preoperative anemia in cardiac surgery: A multicenter cohort study. Circulation. 2008; 117: 478-84
5. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT, Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation: Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007; 116: 471-9
6. Beattie WS, Karkouti K, Wijeysundera DN, Tait G,: Risk associated with preoperative anemia in noncardiac surgery: A single-center cohort study. A nesthesiology. 2009; 110: 574-81
7. Guinn NR, Cooter ML, Weiskopf RB,: Lower hemoglobin concentration decreases time to death in severely anemic patients for whom blood transfusion is not an option. J Trauma Acute Care Surg. 2020; 88: 803-8
8. Loor G, Li L, Sabik JF III, Rajeswaran J, Blackstone EH, Koch CG,: Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and mortality. J Thorac Cardiovasc Surg. 2012; 144: 654-662.e4
9. Weiskopf RB, Glassberg E, Guinn NR, James MFM, Ness PM, Pusateri AE,: The need for an artificial oxygen carrier for disasters and pandemics, including COVID-19. Transfusion. 2020; 60: 3039-45
10. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G, Mitsakakis N, Hare GM,: Acute surgical anemia influences the cardioprotective effects of beta-blockade: A single-center, propensity-matched cohort study. A nesthesiology. 2010; 112: 25-33
11. Ashes C, Judelman S, Wijeysundera DN, Tait G, Mazer CD, Hare GM, Beattie WS,: Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: A single-center cohort study of 44,092 consecutive patients. A nesthesiology. 2013; 119: 777-87
12. Turan A, Cohen B, Rivas E, Liu L, Pu X, Maheshwari K, Farag E, Onal O, Wang J, Ruetzler K, Devereaux PJ, Sessler DI,: Association between postoperative haemoglobin and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Br J Anaesth. 2021; 126: 94-101
13. Turan A, Rivas E, Devereaux PJ, Bravo M, Mao G, Cohen B, Maheshwari K, Pu X, Ruetzler K, Li K, Sessler DI,: Association between postoperative haemoglobin concentrations and composite of non-fatal myocardial infarction and all-cause mortality in noncardiac surgical patients: Post hoc analysis of the POISE-2 trial. Br J Anaesth. 2021; 126: 87-93
14. Shander A, Javidroozi M, Ozawa S, Hare GM,: What is really dangerous: Anaemia or transfusion? Br J Anaesth. 2011; 107 (suppl 1): i41-59
15. Warner MA, Shore-Lesserson L, Shander A, Patel SY, Perelman SI, Guinn NR,: Perioperative anemia: Prevention, diagnosis, and management throughout the spectrum of perioperative care. Anesth Analg. 2020; 130: 1364-80
16. Hare GM, Freedman J, David Mazer C,: Review article: Risks of anemia and related management strategies: Can perioperative blood management improve patient safety? Can J Anaesth. 2013; 60: 168-75
17. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR,: Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study. Lancet. 2011; 378: 1396-407
18. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE,: Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005; 129: 391-400
19. Karkouti K, Djaiani G, Borger MA, Beattie WS, Fedorko L, Wijeysundera D, Ivanov J, Karski J,: Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg. 2005; 80: 1381-7
20. Hogervorst E, Rosseel P, van der Bom J, Bentala M, Brand A, van der Meer N, van de Watering L,: Tolerance of intraoperative hemoglobin decrease during cardiac surgery. Transfusion. 2014; 54 (10 pt 2): 2696-704
21. Spolverato G, Kim Y, Ejaz A, Frank SM, Pawlik TM,: Effect of relative decrease in blood hemoglobin concentrations on postoperative morbidity in patients who undergo major gastrointestinal surgery. JAMA Surg. 2015; 150: 949-56
22. Guinn NR, Cooter ML, Villalpando C, Weiskopf RB,: Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. Transfusion. 2018; 58: 2290-6
23. Abrahamson JR, Read A, Chin K, Mistry N, Joo H, Desjardins JF, Liu E, Thai K, Wilson DF, Vinogradov SA, Maynes JT, Gilbert RE, Connelly KA, Baker AJ, Mazer CD, Hare GMT,: Renal tissue Po(2) sensing during acute hemodilution is dependent on the diluent. Am J Physiol. 2020; 318: R799-R812
24. Hare GM, Tsui AK, Ozawa S, Shander A,: Anaemia: Can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol. 2013; 27: 85-98
25. McLaren AT, Marsden PA, Mazer CD, Baker AJ, Stewart DJ, Tsui AK, Li X, Yucel Y, Robb M, Boyd SR, Liu E, Yu J, Hare GM,: Increased expression of HIF-1alpha, nNOS, and VEGF in the cerebral cortex of anemic rats. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R403-14
26. Tsui AK, Marsden PA, Mazer CD, Adamson SL, Henkelman RM, Ho JJ, Wilson DF, Heximer SP, Connelly KA, Bolz SS, Lidington D, El-Beheiry MH, Dattani ND, Chen KM, Hare GM,: Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia. Proc Natl Acad Sci U S A. 2011; 108: 17544-9
27. Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou YQ, Romanova N, Hare AGM, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT,: Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain. Am J Physiol Regul Integr Comp Physiol. 2018; 314: R611-22
28. Hare GMT, Han K, Leshchyshyn Y, Mistry N, Kei T, Dai SY, Tsui AKY, Pirani RA, Honavar J, Patel RP, Yagnik S, Welker SL, Tam T, Romaschin A, Connelly PW, Beattie WS, Mazer CD,: Potential biomarkers of tissue hypoxia during acute hemodilutional anemia in cardiac surgery: A prospective study to assess tissue hypoxia as a mechanism of organ injury. Can J Anaesth. 2018; 65: 901-13
29. Klein AA, Collier TJ, Brar MS, Evans C, Hallward G, Fletcher SN, Richards T, Association of Cardiothoracic Anaesthetists (ACTA): The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK-The first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia. 2016; 71: 627-35
30. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, Juhl A,: An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion. 2014; 54 (10 pt 2): 2688-95; quiz 2687
31. Weiskopf RB, Beliaev AM, Shander A, Guinn NR, Cap AP, Ness PM, Silverman TA,: Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. Transfusion. 2017; 57: 207-14
32. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM,: Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA. 2008; 299: 2304-12
33. LaPar DJ, Hawkins RB, McMurry TL, Isbell JM, Rich JB, Speir AM, Quader MA, Kron IL, Kern JA, Ailawadi G, Investigators for the Virginia Cardiac Services Quality Initiative: Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery? J Thorac Cardiovasc Surg. 2018; 156: 66-74.e2
34. Loor G, Rajeswaran J, Li L, Sabik JF III, Blackstone EH, McCrae KR, Koch CG,: The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? J Thorac Cardiovasc Surg. 2013; 146: 1480-1487.e6
35. Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, Qureshi S, Lai FY, Kumar T, Richards T, Yao G, Estcourt L, Murphy GJ,: Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: A network meta-analysis. Br J Anaesth. 2021; 126: 149-56
36. Wilson DF, Matschinsky FM,: Metabolic homeostasis: Oxidative phosphorylation and the metabolic requirements of higher plants and animals. J Appl Physiol. 2018; 125: 1183-92
37. Prabhakar NR, Semenza GL,: Oxygen sensing and homeostasis. Physiology (Bethesda). 2015; 30: 340-8
38. Ragoonanan TE, Beattie WS, Mazer CD, Tsui AK, Leong-Poi H, Wilson DF, Tait G, Yu J, Liu E, Noronha M, Dattani ND, Mitsakakis N, Hare GM,: Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. A nesthesiology. 2009; 111: 988-1000
39. Tsui AK, Marsden PA, Mazer CD, Sled JG, Lee KM, Henkelman RM, Cahill LS, Zhou YQ, Chan N, Liu E, Hare GM,: Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia. Am J Physiol Regul Integr Comp Physiol. 2014; 307: R13-25
40. Goodnough LT, Shander A,: Patient blood management. A nesthesiology. 2012; 116: 1367-76
41. Dardashti A, Ederoth P, Algotsson L, Bronden B, Grins E, Larsson M, Nozohoor S, Zinko G, Bjurstein H,: Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology. 2014; 121: 582-90
42. Foroughi M, Mohammadi Z, Majidi Tehrani M, Bakhtiari M, Dabbagh A, Haji Molahoseini M,: The effect of erythropoietin administration on the serum level of YKL-40, pro-BNP and IL-6 in coronary surgery patients. Iran J Pharm Res. 2020; 19: 430-9
43. Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL,: Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: A double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013; 17: R254
44. Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L,: A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: Results of a prospective single-blind randomized controlled trial. Transfusion. 2015; 55: 1644-54
45. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL,: Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011; 115: 929-37
46. Song YR, Lee T, You SJ, Chin HJ, Chae D-W, Lim C, Park K-H, Han S, Kim J-H, Na Y,: Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: A pilot study. Am J Nephrol. 2009; 30: 253-60
47. Drexler C, Macher S, Lindenau I, Holter M, Moritz M, Stojakovic T, Pieber TR, Schlenke P, Amrein K,: High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. Clin Nutr. 2020; 39: 737-45
48. Lin DM, Lin ES, Tran MH,: Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: A systematic review. Transfus Med Rev. 2013; 27: 221-34
49. Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, Macdougall IC, Murphy G, Swinson R, Collier T, Van Dyck L, Browne J, Bradbury A, Dodd M, Evans R, Brealey D, Anker SD, Klein A,: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): A randomised, double-blind, controlled trial. Lancet. 2020; 396: 1353-61
50. Hardy JF, Farmer SL, Auerbach M, Frank SM, Javidroozi M, Leahy MF, Meier J, Ozawa S, Shander A,: Preoperative intravenous iron in anemic patients undergoing major abdominal surgery may not PREVENTT blood transfusions but still contribute to the objectives of patient blood management. Anesth Analg. 2021; 132: 1174-7
51. Cho BC, Serini J, Zorrilla-Vaca A, Scott MJ, Gehrie EA, Frank SM, Grant MC,: Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: Results from a systematic review and meta-analysis. Anesth Analg. 2019; 128: 981-92
52. Kei T, Mistry N, Curley G, Pavenski K, Shehata N, Tanzini RM, Gauthier MF, Thorpe K, Schweizer TA, Ward S, Mazer CD, Hare GMT,: Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anaesth. 2019; 66: 716-31
53. U.S. Food and Drug Administration: Information on erythropoiesis-stimulating agents (ESA) epoetin alfa (marketed as Procrit, Epogen), darbepoetin alfa (marketed as Aranesp). Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-erythropoiesis-stimulating-agents-esa-epoetin-alfa-marketed-procrit-epogen-darbepoetin. Accessed May 29, 2021.
54. Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM, Kaserer A, Hegemann I, Hofmann A, Maisano F, Falk V,: Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: A prospective randomised trial. Lancet. 2019; 393: 2201-12
55. Hare GMT, Cazorla-Bak MP, Ku SFM, Chin K, Mistry N, Sklar MC, Pavenski K, Alli A, Van Rensburg A, Friedrich JO, Baker AJ, Mazer CD,: When to transfuse your acute care patient? A narrative review of the risk of anemia and red blood cell transfusion based on clinical trial outcomes. Can J Anaesth. 2020; 67: 1576-94
56. Shehata N, Mistry N, da Costa BR, Pereira TV, Whitlock R, Curley GF, Scott DA, Hare GMT, Jüni P, Mazer CD,: Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: A meta-analysis. Eur Heart J. 2019; 40: 1081-8
57. Hovaguimian F, Myles PS,: Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: A context-specific systematic review and meta-analysis of randomized controlled trials. A nesthesiology. 2016; 125: 46-61
58. Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, Carson JL, Cichutek K, De Buck E, Devine D, Fergusson D, Folléa G, French C, Frey KP, Gammon R, Levy JH, Murphy MF, Ozier Y, Pavenski K, So-Osman C, Tiberghien P, Volmink J, Waters JH, Wood EM, Seifried E, ICC PBM Frankfurt 2018 Group: Patient blood management: Recommendations from the 2018 Frankfurt Consensus Conference. JAMA. 2019; 321: 983-97
59. Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B, Gregory AJ, de Médicis É Carrier FM, McGuinness S, Young PJ, Byrne K, Villar JC, Royse A, Grocott HP, Seeberger MD, Mehta C, Lellouche F, Hare GMT, Painter TW, Fremes S, Syed S, Bagshaw SM, Hwang NC, Royse C, Hall J, Dai D, Mistry N, Thorpe K, Verma S, Jüni P, Shehata N, TRICS Investigators and Perioperative Anesthesia Clinical Trials Group: Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med. 2018; 379: 1224-33
60. Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP,: Roxadustat treatment for anemia in patients undergoing long-term dialysis. N Engl J Med. 2019; 381: 1011-22
61. Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP,: Roxadustat for anemia in patients with kidney disease not receiving dialysis. N Engl J Med. 2019; 381: 1001-10
62. Zheng Q, Yang H, Sun L, Wei R, Fu X, Wang Y, Huang Y, Liu YN, Liu WJ,: Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis. Pharmacol Res. 2020; 159: 105020